- Coordinator
- Institut De Physique Du Globe De Paris, France
- Runs
- 1 June 2023 to 30 November 2024
- Status
- Finished
- EU funding
- €150k
- Total cost
- —
- Partners
- 1 organisations in 1 countries
- Type
- European Research Council grant
- Grant agreement
- 101059236
What the project is doing
In the project's own words, from its summary on CORDIS.
During the course of the PRISTINE proposal we have developed the first high precision high sensitivity stable isotope measurements for a variety of vital elements, including Zn, and Cu . With these technical advances we realized that we could monitor stable isotopic changes within organisms that open up a new way to study metal homeostasis as well as a new ways of detection diagnosis for diseases, in particular the Alzheimer's disease.
In DAI, we will further explore make use of these unique technical advance to demonstrate the feasibility of using stable isotope geochemistry of metals to detect the early stages of the Alzheimer's disease. to reach this goal, we will combine our technical skills developed during PRISTINE with medical science to demonstrate this proof of concept and if succesful to file a patent. This would represent a unique way to apply isotope cosmochemistry to medical science fields.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Institut De Physique Du Globe De Paris | Paris | France | Coordinator |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI